CN113018222A - Multi-effect cream for barrier repair of sensitive skin - Google Patents
Multi-effect cream for barrier repair of sensitive skin Download PDFInfo
- Publication number
- CN113018222A CN113018222A CN202110387733.5A CN202110387733A CN113018222A CN 113018222 A CN113018222 A CN 113018222A CN 202110387733 A CN202110387733 A CN 202110387733A CN 113018222 A CN113018222 A CN 113018222A
- Authority
- CN
- China
- Prior art keywords
- group
- preparation
- composition
- extract
- butanediol
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/60—Sugars; Derivatives thereof
- A61K8/602—Glycosides, e.g. rutin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/34—Alcohols
- A61K8/345—Alcohols containing more than one hydroxy group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
- A61K8/41—Amines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
- A61K8/42—Amides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/67—Vitamins
- A61K8/678—Tocopherol, i.e. vitamin E
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/73—Polysaccharides
- A61K8/735—Mucopolysaccharides, e.g. hyaluronic acid; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/81—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions involving only carbon-to-carbon unsaturated bonds
- A61K8/8129—Compositions of homopolymers or copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and at least one being terminated by an alcohol, ether, aldehydo, ketonic, acetal or ketal radical; Compositions of hydrolysed polymers or esters of unsaturated alcohols with saturated carboxylic acids; Compositions of derivatives of such polymers, e.g. polyvinylmethylether
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/81—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions involving only carbon-to-carbon unsaturated bonds
- A61K8/8141—Compositions of homopolymers or copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and at least one being terminated by only one carboxyl radical, or of salts, anhydrides, esters, amides, imides or nitriles thereof; Compositions of derivatives of such polymers
- A61K8/8158—Homopolymers or copolymers of amides or imides, e.g. (meth) acrylamide; Compositions of derivatives of such polymers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/92—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof
- A61K8/922—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof of vegetable origin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9789—Magnoliopsida [dicotyledons]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9794—Liliopsida [monocotyledons]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/005—Preparations for sensitive skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/08—Anti-ageing preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/59—Mixtures
- A61K2800/592—Mixtures of compounds complementing their respective functions
- A61K2800/5922—At least two compounds being classified in the same subclass of A61K8/18
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Dermatology (AREA)
- Biotechnology (AREA)
- Engineering & Computer Science (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Botany (AREA)
- Chemical & Material Sciences (AREA)
- Rheumatology (AREA)
- Pharmacology & Pharmacy (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Medicinal Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Gerontology & Geriatric Medicine (AREA)
- Pain & Pain Management (AREA)
- Emergency Medicine (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Cosmetics (AREA)
Abstract
The invention belongs to the technical field of cosmetics, and discloses a multi-effect cream for repairing sensitive skin barriers, which comprises a cetearyl glucoside composition in a group A, jojoba seed oil, tocopherol, a preparation water in a group B, butanediol, a preparation water in a group C, carbomer, a polyacrylamide composition in a group D, a tetrahydroxypropyl ethylenediamine in a group E, a preparation water in a group F, sodium hyaluronate and a preparation butanediol composition in a group G, wherein the preparation components in the group H comprise caprylyl hydroxamic acid compositions PGE-2 prevents redness and erythema, and makes the skin softer after application without reducing the protective capacity of the skin's keratinous barrier.
Description
Technical Field
The invention belongs to the technical field of cosmetics, and particularly relates to a multi-effect cream for repairing a sensitive skin barrier.
Background
Sensitive muscles are individuals with symptoms of facial hyperreactivity to describe their skin, and it is considered that their skin is more vulnerable to the external environment or the invasion of facial products than normal people to cause hyperreactivity, which is problematic skin with symptoms of erythema and skin flushing, and is an excessive reaction of the skin, and an excessive sensory reaction of the skin caused by some external environmental factors including hard water and cosmetics.
Sensitive skin causes various skin problems such as dehydration, stinging heat, flushing, pustules, desquamation, etc., which are of great concern, and thus, a multi-effect cream for barrier repair of sensitive skin is provided.
Disclosure of Invention
In order to solve the above problems of the prior art, the present invention aims to provide a multi-effect cream for barrier repair against the problem of sensitive muscles.
The technical scheme adopted by the invention is as follows: a pleiotropic cream for barrier repair of sensitive muscle skin, which comprises A, B, C, D, E, F, G, H groups of preparations, wherein the ingredients of the A group of preparations comprise cetearyl glucoside composition, jojoba seed oil and tocopherol, the ingredients of the B group of preparations comprise water and butanediol, the ingredients of the C group of preparations comprise water and carbomer, the ingredients of the D group of preparations comprise polyacrylamide composition, the ingredients of the E group of preparations comprise tetrahydroxypropyl ethylenediamine, the ingredients of the F group of preparations comprise water and sodium hyaluronate, the ingredients of the G group of preparations comprise butanediol composition, the ingredients of the H group of preparations comprise caprylyl hydroximic acid composition, and the preparation method comprises the following steps:
s1, cleaning all tools and pot sets used in production, and sterilizing for later use; respectively dispersing and dissolving the preparation C and the preparation F for later use;
s2 adding the preparation of group B, the preparation of group C and the preparation of group F into an emulsifying pot, stirring, heating to 90 deg.C for dissolving completely, and sterilizing at constant temperature for 10 min; adding the group A preparation into an oil phase pot, stirring and heating to 80 ℃, and completely dissolving;
s3, starting homogenizing, pumping the oil phase pot raw materials, continuing homogenizing for 3min after adding, and stirring uniformly; cooling to 78 deg.C, adding the preparation D, homogenizing for 1min, and stirring; defoaming completely at constant temperature;
s4, adding the preparation E, and stirring uniformly;
s5, cooling to 45 ℃, adding the preparation in group G and the preparation in group H, and stirring uniformly;
s6, cooling to 38 ℃, filtering with 100-mesh filter cloth and discharging.
Further, the percentage ratio of the components of the preparation in the group A is cetearyl glucoside composition (2%), jojoba seed oil (6%), tocopherol (0.5%), the percentage ratio of the components of the B group preparation is water (54.23%) and butanediol (8%), the component of the C group preparation comprises water (20%) and carbomer (0.2%), the percentage ratio of the components of the D group preparation is polyacrylamide composition (1.5%), the percentage ratio of the components of the E group preparation is tetrahydroxypropylethylenediamine (0.24%), the component of the F group preparation comprises water (3%) and sodium hyaluronate (0.03%), the percentage ratio of the components of the G group preparation is butanediol composition (3.5%), and the percentage ratio of the components of the H group preparation is caprylhydroxamic acid composition (0.8%).
Still further, the cetearyl glucoside composition of group a formulation (2%) included cetearyl alcohol (5%), cetearyl glucoside (45%), sorbitan olivate (50%).
Furthermore, the polyacrylamide composition (1.5%) in the group D preparation comprises polyacrylamide (40%), C13-14 isoparaffin (15%), laureth-7 (5%), and water (40%).
Furthermore, the butylene glycol composition (3.5%) of the group G preparation comprises water (> 50%), butylene glycol (1-10%), 1, 2-hexanediol (1-5%), carboxymethyl chitosan (1-10%), a chamomile extract (3-12%), a mint leaf extract (2-10%), a pelargonium graveolens extract (2-10%), a purslane extract (2-8%), an aloe barbadensis extract (2-8%), a sophora flavescens root extract (2-8%), sodium benzoate (0.1-0.5%), potassium sorbate (0.1-0.5%) and glycerol (2-10%).
Further, the butylene glycol composition (3.5%) of the group G formulation included water (51%), butylene glycol (4%), 1, 2-hexanediol (2%), carboxymethyl chitosan (5%), a chamomile extract (9%), a mint leaf extract (3%), a geranium extract (7%), a purslane extract (5%), an aloe vera extract (3%), a ginseng root extract (8%), sodium benzoate (0.5%), potassium sorbate (0.5%), and glycerin (2%).
Further, the butylene glycol composition (3.5%) of the group G formulation included water (50.8%), butylene glycol (1%), 1, 2-hexanediol (5%), carboxymethyl chitosan (2%), a chamomile extract (12%), a mint leaf extract (10%), a geranium extract (2%), a purslane extract (2%), an aloe vera extract (8%), a sophora flavescens root extract (2%), sodium benzoate (0.1%), potassium sorbate (0.1%), and glycerin (5%).
Further, the formulation of group H, caprylhydroxamic acid composition (0.8%) included butylene glycol (60%), 1, 2-hexanediol (28%), caprylhydroxamic acid (11%).
The invention has the beneficial effects that:
the multi-effect cream for repairing the sensitive skin barrier provided by the invention has the multiple effects of immediate allergy relief, barrier repair, sedation, moisture retention and oxidation resistance, inhibits the primary reaction of inflammation by regulating cytokines to inhibit IL-1 alpha and TNF-alpha to prevent the reaction from inhibiting IL-6 and IL-8 from reducing redness from the source, and inhibits the secondary reaction of inflammation by regulating lipid mediators to inhibit COX-2 and PGE-2 to prevent redness and erythema.
The multi-effect cream has the effects of barrier repair and moisture preservation, can promote the moisture preservation capability of cells, and can repair the damage of a sebum membrane and a 'brick wall structure' for a long time; the traditional Chinese medicine composition has the effects of treating inflammation characterization, eliminating red swelling, inhibiting bacteria and resisting inflammation, increases the affinity and moisture retention of the formula by using a water molecule softening technology, enables the formula to bear more active ingredients without skin burden, and has higher synergistic effect with active substances. The skin is softer after use without reducing the protective capacity of the skin's keratinous barrier.
Detailed Description
The present invention is further illustrated below with reference to specific examples.
Example 1:
the embodiment provides a pleiotropic cream for barrier repair of sensitive muscle skin, which comprises A, B, C, D, E, F, G, H groups of preparations, wherein the ingredients of the A group of preparations comprise cetearyl glucoside composition, jojoba seed oil and tocopherol, the ingredients of the B group of preparations comprise water and butanediol, the ingredients of the C group of preparations comprise water and carbomer, the ingredients of the D group of preparations comprise polyacrylamide composition, the ingredients of the E group of preparations comprise tetrahydroxypropyl ethylenediamine, the ingredients of the F group of preparations comprise water and sodium hyaluronate, the ingredients of the G group of preparations comprise butanediol composition, the ingredients of the H group of preparations comprise caprylyl hydroximic acid composition, and the preparation method comprises the following steps:
s1, cleaning all tools and pot sets used in production, and sterilizing for later use; respectively dispersing and dissolving the preparation C and the preparation F for later use; s2 adding the preparation of group B, the preparation of group C and the preparation of group F into an emulsifying pot, stirring, heating to 90 deg.C for dissolving completely, and sterilizing at constant temperature for 10 min; adding the group A preparation into an oil phase pot, stirring and heating to 80 ℃, and completely dissolving; s3, starting homogenizing, pumping the oil phase pot raw materials, continuing homogenizing for 3min after adding, and stirring uniformly; cooling to 78 deg.C, adding the preparation D, homogenizing for 1min, and stirring; defoaming completely at constant temperature; s4, adding the preparation E, and stirring uniformly; s5, cooling to 45 ℃, adding the preparation in group G and the preparation in group H, and stirring uniformly; s6, cooling to 38 ℃, filtering with 100-mesh filter cloth and discharging.
Specifically, the percentage ratio of the components of the preparation in the group A is cetearyl glucoside composition (2%), jojoba seed oil (6%), tocopherol (0.5%), the percentage ratio of the components of the B group preparation is water (54.23%) and butanediol (8%), the component of the C group preparation comprises water (20%) and carbomer (0.2%), the percentage ratio of the components of the D group preparation is polyacrylamide composition (1.5%), the percentage ratio of the components of the E group preparation is tetrahydroxypropylethylenediamine (0.24%), the component of the F group preparation comprises water (3%) and sodium hyaluronate (0.03%), the percentage ratio of the components of the G group preparation is butanediol composition (3.5%), and the percentage ratio of the components of the H group preparation is caprylhydroxamic acid composition (0.8%).
Specifically, the proportion of the group A formulation cetearyl glucoside composition (2%) includes cetearyl alcohol (5%), cetearyl glucoside (45%), sorbitan olivate (50%), the proportion of the group D formulation polyacrylamide composition (1.5%) includes polyacrylamide (40%), C13-14 isoparaffin (15%), laureth-7 (5%), water (40%), the proportion of the group G formulation butylene glycol composition (3.5%) includes water (51%), butylene glycol (4%), 1, 2-hexanediol (2%), carboxymethyl chitosan (5%), chamomile extract (9%), peppermint leaf extract (3%), geranium extract (7%), purslane extract (5%), aloe vera extract (3%), and the like, The percentage of the extract of the root of the kuraria (8%), sodium benzoate (0.5%), potassium sorbate (0.5%), glycerin (2%), and the composition of the group H preparation caprylyl hydroximic acid (0.8%) comprises butanediol (60%), 1, 2-hexanediol (28%), and caprylyl hydroximic acid (11%).
Example 2:
the formula and the ratio of the multi-effect cream for sensitive skin barrier repair in the embodiment are basically the same as those in the embodiment 1, and the difference is that: a pleiotropic cream for barrier repair of sensitive muscle skin, which comprises A, B, C, D, E, F, G, H groups of preparations, wherein the ingredients of the A group of preparations comprise cetearyl glucoside composition, jojoba seed oil and tocopherol, the ingredients of the B group of preparations comprise water and butanediol, the ingredients of the C group of preparations comprise water and carbomer, the ingredients of the D group of preparations comprise polyacrylamide composition, the ingredients of the E group of preparations comprise tetrahydroxypropyl ethylenediamine, the ingredients of the F group of preparations comprise water and sodium hyaluronate, the ingredients of the G group of preparations comprise butanediol composition, the ingredients of the H group of preparations comprise caprylyl hydroximic acid composition, and the preparation method comprises the following steps: s1, cleaning all tools and pot sets used in production, and sterilizing for later use; respectively dispersing and dissolving the preparation C and the preparation F for later use; s2 adding the preparation of group B, the preparation of group C and the preparation of group F into an emulsifying pot, stirring, heating to 90 deg.C for dissolving completely, and sterilizing at constant temperature for 10 min; adding the group A preparation into an oil phase pot, stirring and heating to 80 ℃, and completely dissolving; s3, starting homogenizing, pumping the oil phase pot raw materials, continuing homogenizing for 3min after adding, and stirring uniformly; cooling to 78 deg.C, adding the preparation D, homogenizing for 1min, and stirring; defoaming completely at constant temperature; s4, adding the preparation E, and stirring uniformly; s5, cooling to 45 ℃, adding the preparation in group G and the preparation in group H, and stirring uniformly; s6, cooling to 38 ℃, filtering with 100-mesh filter cloth and discharging.
Specifically, the percentage ratio of the components of the preparation in the group A is cetearyl glucoside composition (2%), jojoba seed oil (6%), tocopherol (0.5%), the percentage ratio of the components of the B group preparation is water (54.23%) and butanediol (8%), the component of the C group preparation comprises water (20%) and carbomer (0.2%), the percentage ratio of the components of the D group preparation is polyacrylamide composition (1.5%), the percentage ratio of the components of the E group preparation is tetrahydroxypropylethylenediamine (0.24%), the component of the F group preparation comprises water (3%) and sodium hyaluronate (0.03%), the percentage ratio of the components of the G group preparation is butanediol composition (3.5%), and the percentage ratio of the components of the H group preparation is caprylhydroxamic acid composition (0.8%).
Specifically, the proportions of the group A formulation cetearyl glucoside composition (2%) include cetearyl alcohol (5%), cetearyl glucoside (45%), sorbitan olivate (50%), and the proportion of the group D formulation polyacrylamide composition (1.5%) includes polyacrylamide (40%), C13-14 isoparaffin (15%), laureth-7 (5%), water (40%), and the proportions of the group G formulation butylene glycol composition (3.5%), including water (50.8%), butylene glycol (1%), 1, 2-hexanediol (5%), carboxymethyl chitosan (2%), chamomile extract (12%), peppermint leaf extract (10%), geranium extract (2%), purslane extract (2%), aloe vera extract (8%), and mixtures thereof, The percentage of the extract of the root of the kuraria (2%), sodium benzoate (0.1%), potassium sorbate (0.1%), glycerin (5%), and the composition of the group H preparation caprylyl hydroximic acid (0.8%) comprises butanediol (60%), 1, 2-hexanediol (28%), and caprylyl hydroximic acid (11%).
The present invention is not limited to the above-described alternative embodiments, and various other forms of products can be obtained by anyone in light of the present invention. The above detailed description should not be taken as limiting the scope of the invention, which is defined in the claims, and which the description is intended to be interpreted accordingly.
Claims (8)
1. The multi-effect cream for sensitive skin barrier repair is characterized in that: the preparation comprises A, B, C, D, E, F, G, H groups of preparations, wherein the ingredients of the A group of preparations comprise cetearyl glucoside composition, jojoba seed oil and tocopherol, the ingredients of the B group of preparations comprise water and butanediol, the ingredients of the C group of preparations comprise water and carbomer, the ingredients of the D group of preparations comprise polyacrylamide composition, the ingredients of the E group of preparations comprise tetrahydroxypropyl ethylenediamine, the ingredients of the F group of preparations comprise water and sodium hyaluronate, the ingredients of the G group of preparations comprise butanediol composition, the ingredients of the H group of preparations comprise caprylyl hydroximic acid composition, and the preparation method comprises the following steps:
s1, cleaning all tools and pot sets used in production, and sterilizing for later use; respectively dispersing and dissolving the preparation C and the preparation F for later use;
s2 adding the preparation of group B, the preparation of group C and the preparation of group F into an emulsifying pot, stirring, heating to 90 deg.C for dissolving completely, and sterilizing at constant temperature for 10 min; adding the group A preparation into an oil phase pot, stirring and heating to 80 ℃, and completely dissolving;
s3, starting homogenizing, pumping the oil phase pot raw materials, continuing homogenizing for 3min after adding, and stirring uniformly; cooling to 78 deg.C, adding the preparation D, homogenizing for 1min, and stirring; defoaming completely at constant temperature;
s4, adding the preparation E, and stirring uniformly;
s5, cooling to 45 ℃, adding the preparation in group G and the preparation in group H, and stirring uniformly;
s6, cooling to 38 ℃, filtering with 100-mesh filter cloth and discharging.
2. The multi-effect cream for sensitive muscle skin barrier repair of claim 1, wherein: the composition of the preparation group A comprises, by percentage, a cetearyl glucoside composition (2%), jojoba seed oil (6%) and tocopherol (0.5%), the composition of the preparation group B comprises, by percentage, water (54.23%) and butanediol (8%), the composition of the preparation group C comprises, by percentage, water (20%) and carbomer (0.2%), the composition of the preparation group D comprises, by percentage, a polyacrylamide composition (1.5%), the composition of the preparation group E comprises, by percentage, tetrahydroxypropylethylenediamine (0.24%), the composition of the preparation group F comprises, by percentage, water (3%), sodium hyaluronate (0.03%), the composition of the preparation group G comprises, by percentage, a butanediol composition (3.5%), and the composition of the preparation group H comprises, by percentage, a caprylhydroxamic acid composition (0.8%).
3. The multi-effect cream for sensitive muscle skin barrier repair of claim 2, wherein: the group a formulation cetearyl glucoside composition (2%) included cetearyl alcohol (5%), cetearyl glucoside (45%), sorbitan olivate (50%).
4. The multi-effect cream for sensitive muscle skin barrier repair of claim 2, wherein: the polyacrylamide composition (1.5%) of the D group preparation comprises polyacrylamide (40%), C13-14 isoparaffin (15%), laureth-7 (5%) and water (40%).
5. The multi-effect cream for sensitive muscle skin barrier repair of claim 2, wherein: the composition of the G group preparation butanediol (3.5%) comprises water (> 50%), butanediol (1-10%), 1, 2-hexanediol (1-5%), carboxymethyl chitosan (1-10%), a chamomile extract (3-12%), a mint leaf extract (2-10%), a pelargonium graveolens extract (2-10%), a purslane extract (2-8%), an aloe vera extract (2-8%), a picrasma root extract (2-8%), sodium benzoate (0.1-0.5%), potassium sorbate (0.1-0.5%) and glycerol (2-10%).
6. The multi-effect cream for sensitive muscle skin barrier repair of claim 2, wherein: the composition of the butanediol (3.5%) in the group G preparation comprises water (51%), butanediol (4%), 1, 2-hexanediol (2%), carboxymethyl chitosan (5%), a chamomile extract (9%), a mint leaf extract (3%), a geranium extract (7%), a purslane extract (5%), an aloe barbadensis extract (3%), a picrasma root extract (8%), sodium benzoate (0.5%), potassium sorbate (0.5%) and glycerol (2%).
7. The multi-effect cream for sensitive muscle skin barrier repair of claim 2, wherein: the composition of the butanediol (3.5%) in the group G preparation comprises water (50.8%), butanediol (1%), 1, 2-hexanediol (5%), carboxymethyl chitosan (2%), a chamomile extract (12%), a mint leaf extract (10%), a pelargonium graveolens extract (2%), a purslane extract (2%), an aloe barbadensis extract (8%), a picrasma root extract (2%), sodium benzoate (0.1%), potassium sorbate (0.1%) and glycerol (5%).
8. The multi-effect cream for sensitive muscle skin barrier repair of claim 2, wherein: the H group preparation of caprylyl hydroximic acid composition (0.8%) comprises butanediol (60%), 1, 2-hexanediol (28%), and caprylyl hydroximic acid (11%).
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202110387733.5A CN113018222A (en) | 2021-04-12 | 2021-04-12 | Multi-effect cream for barrier repair of sensitive skin |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202110387733.5A CN113018222A (en) | 2021-04-12 | 2021-04-12 | Multi-effect cream for barrier repair of sensitive skin |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN113018222A true CN113018222A (en) | 2021-06-25 |
Family
ID=76456447
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202110387733.5A Pending CN113018222A (en) | 2021-04-12 | 2021-04-12 | Multi-effect cream for barrier repair of sensitive skin |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN113018222A (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN115518017A (en) * | 2022-10-28 | 2022-12-27 | 广州市婷采化妆品有限公司 | Skin care product with soothing and repairing effects and preparation method thereof |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN106727168A (en) * | 2017-03-18 | 2017-05-31 | 广州臻颜化妆品有限公司 | With skin care compositions for repairing sensitive skin effect and its preparation method and application |
| CN111329782A (en) * | 2020-04-27 | 2020-06-26 | 福建百想生物科技有限公司 | Skin care product containing ceramide composition and preparation method thereof |
| CN111920728A (en) * | 2020-07-14 | 2020-11-13 | 爱西美(珠海)生物技术有限公司 | Cosmetic relieving and repairing composition and cosmetic |
-
2021
- 2021-04-12 CN CN202110387733.5A patent/CN113018222A/en active Pending
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN106727168A (en) * | 2017-03-18 | 2017-05-31 | 广州臻颜化妆品有限公司 | With skin care compositions for repairing sensitive skin effect and its preparation method and application |
| CN111329782A (en) * | 2020-04-27 | 2020-06-26 | 福建百想生物科技有限公司 | Skin care product containing ceramide composition and preparation method thereof |
| CN111920728A (en) * | 2020-07-14 | 2020-11-13 | 爱西美(珠海)生物技术有限公司 | Cosmetic relieving and repairing composition and cosmetic |
Non-Patent Citations (1)
| Title |
|---|
| 广州汇聚国际生物科技有限公司: "臻美靓肤润颜霜", 《国产非特殊用途化妆品备案平台，网址：HTTP://FTBA.NMPA.GOV.CN:8181/FTBAN/ITOWNET/HZP_BA/FW/PZ.JSP?PROCESSID=20191218075302P3KYF&NID=20191218075302P3KYF》 * |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN115518017A (en) * | 2022-10-28 | 2022-12-27 | 广州市婷采化妆品有限公司 | Skin care product with soothing and repairing effects and preparation method thereof |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| KR101752451B1 (en) | Cosmetic composition having anti-inflammatory activity | |
| CN111728907B (en) | Composition for relieving and resisting allergy, preparation method thereof and application thereof in cosmetics | |
| CN110693767B (en) | Glacier mineral mud film with skin cleaning effect and preparation method thereof | |
| CN112076133A (en) | Compound plant acne-removing composition and preparation method and application thereof | |
| CN111803422B (en) | Oil control composition and application thereof | |
| CN103040689A (en) | Eucommia seed oil based whitening and moisturizing cream and preparation method thereof | |
| JP2007269743A (en) | Skin care preparation | |
| CN111249195B (en) | Refreshing astringent lotion and preparation method thereof | |
| CN114129496A (en) | Formula and preparation method of repairing and relieving gel | |
| CN112472653A (en) | Acne-removing aloe gel and preparation method thereof | |
| CN113018222A (en) | Multi-effect cream for barrier repair of sensitive skin | |
| CN108158938A (en) | A kind of Pimple removing scream of the ingredient containing American cockroach and preparation method thereof | |
| KR20100134323A (en) | A composition for anti-sebum and acne-remedy cosmetics | |
| CN109431880B (en) | Whitening repairing agent and preparation method of sleeping mask with whitening repairing function | |
| JPH1029927A (en) | Antiaging agent | |
| CN114767603A (en) | Acne-removing cosmetic composition containing red ginseng extract | |
| JP2007320950A (en) | Hyaluronidase inhibitor and skin care composition | |
| KR100865562B1 (en) | Cmposition make use of beauty | |
| KR101938301B1 (en) | Anti-acne composition comprising extracts of rubus coreanus, and willow or propolis | |
| CN115282092A (en) | Composition for balancing water and oil of skin and application thereof | |
| CN116139058B (en) | Allergy-relieving repair gel and preparation process thereof | |
| CN115364002B (en) | Foundation liquid with acne removing effect and preparation method thereof | |
| CN113425648A (en) | Soothing gel of anti-inflammatory remedial composition containing multiple plant extracts | |
| CN108938522B (en) | Makeup removing lotion containing PEG-12 monolaurate and preparation method thereof | |
| KR101974556B1 (en) | Anti-acne composition comprising extracts of rubus coreanus, and propolis |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20210625 |
|
| RJ01 | Rejection of invention patent application after publication |